Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.
A man living with advanced liver cancer has seen his tumour shrink by over half as “exciting” new clinical trials are ...
The CytoMAD tool leverages microfluidic technology for 'label-free' imaging, allowing clinicians to examine tumour cells.
This study investigated the long-term prognosis and clinical course of patients who survived for more than 5 years after hepatocellular carcinoma (HCC) diagnosis.This retrospective cohort study used ...
Researchers assessed the prognostic significance of older age and comorbidity burden on overall survival in patients with hepatocellular carcinoma.
"The applications include cancer subtype discovery, text classification, medical imaging, etc. With AI, you can actually use these advances during surgery to see what stage the cancer is in ...
Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin’s Clinical Research Center for ...
E-mail: [email protected] Cancer Immunol Res 2025;13:162–70 Current address for T. Kobayashi: Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.
7 Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China Objective Hepatocellular carcinoma (HCC) is heterogeneous, especially in multifocal tumours, ...
Objective: To characterize and further compare the immune cell populations of the tumor microenvironment (TME) in both clear cell and papillary renal cell carcinoma (RCC) using heavy metal-labeled ...
A sensation of fullness beneath the ribs on the right side A similar feeling under the ribs on the left side Yellowing of the eyes and skin A swollen abdomen, as if it’s accumulating fluid Hepatitis B ...
This dual-action approach could be transformative for cancer vaccine development." The research team engineered these hydrogels to deliver a specific peptide that targets hepatocellular carcinoma ...